10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/Ep3zggR9TK

これはすごいのでは 常識なんだろうか /10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/jVIf88VqfN

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/wnSwadT4Nv

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. The comparative... https://t.co/jzNwiZ56Mv

RT @NEJM: Original Article: 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized #ProstateCancer…

Historia natural! El que busca encuentra lo que no busca! https://t.co/FInq39m86V

RT @NEJM: Original Article: 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized #ProstateCancer…

RT @NEJM: Original Article: 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized #ProstateCancer…

RT @NEJM: Original Article: 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized #ProstateCancer…

RT @NEJM: Original Article: 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized #ProstateCancer…

Speaks loudly. $PFE $MDVN @MaverickNY https://t.co/oUBvqWOzaH

Original Article: 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized #ProstateCancer https://t.co/nlI4wTKhlu https://t.co/W8l7Yk5UCZ

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/Va9kvSWMp6

RT @NibBiotec: 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer https://t.co/2Va4cruWrC

Results published of first successful #RCT of surgery, #radiation or #ActiveMonitoring for localized #ProstateCancer https://t.co/UnRwfVw1n6

Reciente plática en reunión social: MUERTE x ca d próstata localizado igual observar vs radioterapia vs cirugía https://t.co/A9jzgMZCSR

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/LloyYHeZUk

median of 10 years, prostate-cancer–mortality was low irrespective of the treatment assigned #hpm https://t.co/bo4MnYsHe8

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/dHyoIABcue

https://t.co/5bpNKKsLju

Great example of complex trial (n=1600) that informs decision making. QoL & survival. Surgery v RadioRx v Surveillance 4 prostate cancer? https://t.co/RZ1ixW1MXE

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized #Prostate Cancer — NEJM https://t.co/S9iGdUtMgn #menshealth

New Entry at 2 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate C... https://t.co/CXu4yzZWLL #paperazzi

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/qtJcmxlXjQ

ProtecT: at 10 ys Rxtherapy, surgery, AS show no difference in OS. AS doubles metastasis risk and progression risk. https://t.co/JKBy4QUS4z

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. https://t.co/U0Kd8VgXac #prostatecancer

RT @DrewMoghanaki: Did anyone have doubts, at least with legitimacy? #radonc #pcsm https://t.co/yvnmq5NXmz

RT @DrewMoghanaki: Did anyone have doubts, at least with legitimacy? #radonc #pcsm https://t.co/yvnmq5NXmz

RT @DrewMoghanaki: Did anyone have doubts, at least with legitimacy? #radonc #pcsm https://t.co/yvnmq5NXmz

RT @DrewMoghanaki: Did anyone have doubts, at least with legitimacy? #radonc #pcsm https://t.co/yvnmq5NXmz

Did anyone have doubts, at least with legitimacy? #radonc #pcsm https://t.co/yvnmq5NXmz

RT @NibBiotec: 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer https://t.co/2Va4cruWrC

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer https://t.co/2Va4cruWrC

RT @NEJM: Original Article: Mortality and Clinical Outcomes in the ProtecT Trial https://t.co/nlI4wTKhlu #prostatecancer https://t.co/NH2nC…

今日の抄読会は前立腺癌の治療について。治療成績やQOLを考えるとまずは待機療法だろうが、結局6割くらいは手術や放射線療法になっている。悩ましい問題。 https://t.co/0Xo2cCO3EM https://t.co/nVRrHfIEoy

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/AH88ffocpF

RT @NEJM: Original Article: PSA-Detected #ProstateCancer — To Treat or Not to Treat https://t.co/nlI4wTKhlu https://t.co/SzXt3YPHsu

RT @ZEROCancer: 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer https://t.co/xYSYD2upJr

RT @sabinbmotwanimd: Long awaited results of the ProtecT study in @NEJM published today https://t.co/2rstXGHllD. #radonc #pcsm

RT @SteveLaitner: There really is absolutely no point in screening to find it then is there!?? @felly500 @mgtmccartney @angelaraffle…

RT @SteveLaitner: There really is absolutely no point in screening to find it then is there!?? @felly500 @mgtmccartney @angelaraffle…

RT @ZEROCancer: 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer https://t.co/xYSYD2upJr

RT @ZEROCancer: 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer https://t.co/xYSYD2upJr

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer https://t.co/xYSYD2upJr

There really is absolutely no point in screening to find it then is there!?? @felly500 @mgtmccartney @angelaraffle @muirgray #offnhsmenu https://t.co/3Qb3DtZDZa

For some types of slow-growing blood cancer or low-risk prostate cancer, doctors offer another option: forgo... https://t.co/rRJNlgVDDh

For some types of slow-growing blood cancer or low-risk prostate cancer, doctors offer another option: forgo... https://t.co/EA3NnXm8fv

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer (No diff in mortality) https://t.co/xrq28mXnFY

#Longevity Coaching Tip O’ the Day-Prosuate cancer treat or leave? NEJM article gives odds of survival, progression https://t.co/RN0D6K59Y9

@dralbala joins @ConversationJax today 5pm to discuss AS, surgery vs radiation for #ProstateCancer @NEJM @wokvnews https://t.co/S47XDkJUdm

#overdiagnosis #overtreatment This RCT shows that our treatment of prostate cancer doesn't affect mortality https://t.co/tGqLTWwHx0

Original Article: 10-Year Outcomes after Monitoring, Surgery, or #Radiotherapy for Localized https://t.co/z1QDls0iMP

#NEJM 10 ans de suivi après traitement d'un cancer de la prostate localisé : chirurgie ou radiothérapie ; la mortalité observée est faible https://t.co/FdKxYOr2tM

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized #Prostate #Cancer — NEJM https://t.co/PzAs5N8H7n

Monitoring, surgery, and radiotherapy for localized #prostatecancer all similarly (and highly) effective. https://t.co/5ZgTT6zNOm

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/JOWaIRZcdl

Resultados a 10 anos de cirugia, radioterapia o monitoreo de Ca de prostata localizado — NEJM https://t.co/TqndJHfzwC

10 year study that evaluated psa screening effectiveness for prostate cancer: https://t.co/TWwaVtbMJs

Original Article: 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized #ProstateCancer https://t.co/IvJMHyKOCJ

Resultados del ERC ProtecT (VA vs PR vs RT): sin diferencias en SCE pero con más progresión y MTS con VA q con tto. https://t.co/1FMXwWdgDI

#cancer#próstata. No diferencias entre Cirugia vs radioterpia. No https://t.co/WQn029L38v

10-Year Outcomes After Monitoring, Surgery, or Radiotherapy for Localized #ProstateCancer https://t.co/ZADYTfVdUW

So if you have a localised prostate cancer you may as well do nothing https://t.co/b1n3b9hYfj

RT @CaulfieldTim: Prostate cancer study: Monitoring, surgery, or radiotherapy? No difference in outcome: https://t.co/FHaJyVOKiI #ChooseWis…

RT @CaulfieldTim: Prostate cancer study: Monitoring, surgery, or radiotherapy? No difference in outcome: https://t.co/FHaJyVOKiI #ChooseWis…

@jimharty @austinpbyrne @drdavidsamadi thanks Jim. Latest publication here: https://t.co/XWuzh8JFZk

Be informed before deciding watchful waiting, radiotherapy or surgery for prostate cancer. https://t.co/JE3uFJ37MC

RT @drdhanlon: The PSA Dilemma just got worse https://t.co/SLhn1vgoZm @ICGPnews

Effectiveness of treatments for PSA detected prostate cancer. 10 year survival unaffected by treatment! https://t.co/FpSougZlto

RT @drdhanlon: The PSA Dilemma just got worse https://t.co/SLhn1vgoZm @ICGPnews

Has anyone had a chance to evaluate new NEJM paper, active monitoring vs surgery or rads #prostate CA?#pathJC https://t.co/B1UL0O5JVJ

More gruesome numbers from the world of prostate screening. Early treatment = minimal benefit and maximal harm. https://t.co/YMYHvFkJly

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer https://t.co/Pyx7W0eIiQ via @NEJM

RT @CaulfieldTim: Prostate cancer study: Monitoring, surgery, or radiotherapy? No difference in outcome: https://t.co/FHaJyVOKiI #ChooseWis…

RT @WilliamDale_MD: Prostate cancer is now a chronic disease. #GeriOnc https://t.co/SlNC0Xp9iN

RT @WilliamDale_MD: Prostate #cancer as a chronic disease. #GeriOnc https://t.co/yGutb2JLz3

RT @NEJM: Original Article: Mortality and Clinical Outcomes in the ProtecT Trial https://t.co/nlI4wTKhlu #prostatecancer https://t.co/NH2nC…

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized #Prostate Cancer — NEJM https://t.co/pOCH6zSFqL

RT @drdhanlon: The PSA Dilemma just got worse https://t.co/SLhn1vgoZm @ICGPnews

The PSA Dilemma just got worse https://t.co/SLhn1vgoZm @ICGPnews

RT @finn_corinne: Amazing study. We now need to obtain similar data in early stage NSCLC with SABR https://t.co/EPBuH8aN5U

RT @NEJM: Original Article: Mortality and Clinical Outcomes in the ProtecT Trial https://t.co/nlI4wTKhlu #prostatecancer https://t.co/NH2nC…

RT @NEJM: Original Article: Mortality and Clinical Outcomes in the ProtecT Trial https://t.co/nlI4wTKhlu #prostatecancer https://t.co/NH2nC…

RT @finn_corinne: Amazing study. We now need to obtain similar data in early stage NSCLC with SABR https://t.co/EPBuH8aN5U

RT @fischmd: Mortality was low irrespective of the treatment assigned (surgery, XRT, or active monitoring), #pcsm https://t.co/gS5fb8ujUo

RT @TCDRadTher: Excellent long term results of radiation therapy for prostate cancer. https://t.co/gL6VBNFi6M

Mortality was low irrespective of the treatment assigned (surgery, XRT, or active monitoring), #pcsm https://t.co/gS5fb8ujUo

RT @Newhealthpsych: It's not easy being a patient - or a doctor - the evidence keeps changing https://t.co/ggmBifhW3F

Nearly all men will survive 10 years after a diagnosis of early #prostatecancer, regardless of treatment. https://t.co/zTyYmmAJDQ

RT @WilliamDale_MD: Prostate #cancer as a chronic disease. #GeriOnc https://t.co/yGutb2JLz3

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/yuMOv3IjpO

RT @LoebStacy: Hot off the press: ProtecT randomized trial surgery vs radiation vs active monitoring for #prostatecancer in @NEJM https://…

RT @LoebStacy: Hot off the press: ProtecT randomized trial surgery vs radiation vs active monitoring for #prostatecancer in @NEJM https://…

RT @LoebStacy: Hot off the press: ProtecT randomized trial surgery vs radiation vs active monitoring for #prostatecancer in @NEJM https://…

RT @_JosephLi: Surgery, radiation & active monitoring all assoc w low mortality in localized prostate CA: a 10 yr study https://t.co/BXzBRI…

Must read.. 10 year outcomes https://t.co/3dm2k32J0x

RT @AEDeGraciaNieto: This may be the end of active survilance in prostate cancer. What do you think? @uroweb @infoAEU https://t.co/WQm4lOtC…

RT @AEDeGraciaNieto: This may be the end of active survilance in prostate cancer. What do you think? @uroweb @infoAEU https://t.co/WQm4lOtC…

RT @AEDeGraciaNieto: This may be the end of active survilance in prostate cancer. What do you think? @uroweb @infoAEU https://t.co/WQm4lOtC…

RT @PeterGorayski: 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/8OBb4nMPhX